Experts advocate holistic Semaglutide use as therapy goes off patent in India
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Subscribe To Our Newsletter & Stay Updated